MedPath

Dyrenium

DYRENIUM (triamterene USP) Capsules 50 mg and 100 mg potassium-sparing diuretic

Approved
Approval ID

ffe24e3d-cfe8-4d5a-8213-69f0bbc9f4d5

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 6, 2017

Manufacturers
FDA

Carilion Materials Management

DUNS: 079239644

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Triamterene

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68151-1494
Application NumberNDA013174
Product Classification
M
Marketing Category
C73594
G
Generic Name
Triamterene
Product Specifications
Route of AdministrationORAL
Effective DateApril 29, 2015
FDA Product Classification

INGREDIENTS (9)

TRIAMTERENEActive
Quantity: 50 mg in 1 1
Code: WS821Z52LQ
Classification: ACTIB
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
D&C RED NO. 33Inactive
Code: 9DBA0SBB0L
Classification: IACT
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT
LACTOSE, UNSPECIFIED FORMInactive
Code: J2B2A4N98G
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Dyrenium - FDA Drug Approval Details